Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
18.75
+0.61 (3.36%)
At close: Nov 13, 2026, 4:00 PM EST
18.80
+0.05 (0.27%)
Pre-market: Nov 16, 2026, 7:00 AM EST

Acadia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
362.23391226.45-61.29-215.98-167.87
Depreciation & Amortization
12.7311.7615.885.552.033.34
Loss (Gain) From Sale of Assets
0.17--146.52---
Loss (Gain) From Sale of Investments
-1.31-5.42-9.3-12.12-6.280.08
Stock-Based Compensation
62.3252.1467.0566.4268.263.62
Other Operating Activities
-225.8-249.88----
Change in Accounts Receivable
-45.17-22.72-0.47-36.072.17-16.12
Change in Inventory
0.44-18.2-49.55-28.812.42-4.21
Change in Accounts Payable
-5.4-5.29-1.354.85.87-1.62
Change in Other Net Operating Assets
-62.67-43.5555.5378.2227.54-2.88
Operating Cash Flow
97.53109.84157.7216.7-114.04-125.66
Operating Cash Flow Growth
-50.98%-30.36%844.31%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-15.55-4.69-0.52-0.05--1.12
Sale of Property, Plant & Equipment
--146.52---
Sale (Purchase) of Intangibles
--98.84--40--
Investment in Securities
-68.72-199.04-176.5372.0573.24-69.98
Investing Cash Flow
-84.27-302.56-30.543273.24-71.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
49.2649.886.8525.138.218.16
Financing Cash Flow
49.2649.886.8525.138.218.16

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.220.03-0.09-0.020.010.01
Net Cash Flow
62.74-142.82133.9373.81-32.59-178.59

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
81.99105.15157.216.65-114.04-126.78
Free Cash Flow Growth
-58.55%-33.11%844.01%---
Free Cash Flow Margin
6.82%9.81%16.41%2.29%-22.05%-26.19%
Free Cash Flow Per Share
0.470.620.940.10-0.70-0.79
Levered Free Cash Flow
46.27-153.66270.0828.44-34.96-65.26
Unlevered Free Cash Flow
46.27-153.66270.0828.44-34.96-65.26

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
25.1725.1719.525.852.191.04
Change in Working Capital
-112.8-89.764.1618.1337.99-24.82
SEC Filings: 10-K · 10-Q